Fluicell.

Biotechnology Research | Sweden

Client

Fluicell

Fluicell

/

Duration

8 Weeks

8 Weeks

/

Year

2025

2025

/

Status

Live & Operational

Live & Operational

/

The Challenge

(01)

Growing data volumes

Fluicell is a pioneering Swedish biotech company based in Gothenburg, specializing in high-precision tissue engineering and microfluidics. They develop innovative solutions for regenerative medicine and drug screening, requiring meticulous handling of complex single-cell analysis data. The company faced a critical inflection point: as the number of long-term development projects grew, there was an increasing need for the company to update its way of handling experimental data in order to maintain research efficiency. In short, they needed a sophisticated database solution to turn their wealth of research output into actionable scientific intelligence.

/

The Solution

(02)

Modular Architecture, Complex Querying & Agile Development

We architected a robust, scalable solution and established a dynamic database schema capable of handling complex relationships between samples and entries. To guarantee a best-in-class user experience, we engineered a seamless interface for their file management, bridging the gap between complex data structures and effortless file retrieval. We delivered a modular system designed for longevity and expansion. By taking full ownership of the software lifecycle, we embedded comprehensive audit trails and user activity tracking, ensuring compliance while creating a foundation that can easily adapt to future tissue therapeutics requirements.

/

The Result

(03)

Centralized intelligence. Accelerated research.

We successfully deployed the comprehensive database solution with an immediate transition to a centralized, digital asset management system without operational downtime. The new system enables complex cross-experiment analysis that directly supports efficient drug screening and regenerative medicine development. Fluicell now operates on a scalable platform with full audit capabilities. The modular architecture ensures that as their research volume grows, the system grows with them, securing their position at the cutting edge of microfluidics technology.